42 USC 299b-31 - Quality measure development

The Secretary, in consultation with the Director of the Agency for Healthcare Research and Quality and the Administrator of the Centers for Medicare & Medicaid Services, shall identify, not less often than triennially, gaps where no quality measures exist and existing quality measures that need improvement, updating, or expansion, consistent with the national strategy under section 280j of this title, to the extent available, for use in Federal health programs. In identifying such gaps and existing quality measures that need improvement, the Secretary shall take into consideration—

(A)

the gaps identified by the entity with a contract under section 1890(a) of the Social Security Act [42 U.S.C. 1395aaa(a)] and other stakeholders;

(B)

quality measures identified by the pediatric quality measures program under section 1139A of the Social Security Act [42 U.S.C. 1320b–9a]; and

(C)

quality measures identified through the Medicaid Quality Measurement Program under section 1139B of the Social Security Act [42 U.S.C. 1320b–9b].

(2)

Publication

(c)

Grants or contracts for quality measure development

(1)

In general

(2)

Prioritization in the development of quality measures

In awarding grants, contracts, or agreements under this subsection, the Secretary shall give priority to the development of quality measures that allow the assessment of—

(A)

health outcomes and functional status of patients;

(B)

the management and coordination of health care across episodes of care and care transitions for patients across the continuum of providers, health care settings, and health plans;

(C)

the experience, quality, and use of information provided to and used by patients, caregivers, and authorized representatives to inform decisionmaking about treatment options, including the use of shared decisionmaking tools and preference sensitive care (as defined in section 299b–36 of this title);

(D)

the meaningful use of health information technology;

(E)

the safety, effectiveness, patient-centeredness, appropriateness, and timeliness of care;

(F)

the efficiency of care;

(G)

the equity of health services and health disparities across health disparity populations (as defined in section 285t 1

 See References in Text note below.

of this title) and geographic areas;

(H)

patient experience and satisfaction;

(I)

the use of innovative strategies and methodologies identified under section 299b–33 of this title; and

(J)

other areas determined appropriate by the Secretary.

(3)

Eligible entities

To be eligible for a grant or contract under this subsection, an entity shall—

(A)

have demonstrated expertise and capacity in the development and evaluation of quality measures;

(B)

have adopted procedures to include in the quality measure development process—

(i)

the views of those providers or payers whose performance will be assessed by the measure; and

(ii)

the views of other parties who also will use the quality measures (such as patients, consumers, and health care purchasers);

(C)

collaborate with the entity with a contract under section 1890(a) of the Social Security Act [42 U.S.C. 1395aaa(a)] and other stakeholders, as practicable, and the Secretary so that quality measures developed by the eligible entity will meet the requirements to be considered for endorsement by the entity with a contract under such section 1890(a);

(D)

have transparent policies regarding governance and conflicts of interest; and

(E)

submit an application to the Secretary at such time and in such manner, as the Secretary may require.

(4)

Use of funds

An entity that receives a grant, contract, or agreement under this subsection shall use such award to develop quality measures that meet the following requirements:

(A)

Such measures support measures required to be reported under the Social Security Act [42 U.S.C. 301 et seq.], where applicable, and in support of gaps and existing quality measures that need improvement, as described in subsection (b)(1)(A).

(B)

Such measures support measures developed under section 1139A of the Social Security Act [42 U.S.C. 1320b–9a] and the Medicaid Quality Measurement Program under section 1139B of such Act [42 U.S.C. 1320b–9b], where applicable.

(C)

To the extent practicable, data on such quality measures is able to be collected using health information technologies.

(D)

Each quality measure is free of charge to users of such measure.

(E)

Each quality measure is publicly available on an Internet website.

(d)

Other activities by the Secretary

(e)

Coordination of grants

(f)

Development of outcome measures

(1)

In general

(2)

Categories of measures

The measures developed under this subsection shall include, to the extent determined appropriate by the Secretary—

(A)

outcome measurement for acute and chronic diseases, including, to the extent feasible, the 5 most prevalent and resource-intensive acute and chronic medical conditions; and

(B)

outcome measurement for primary and preventative care, including, to the extent feasible, measurements that cover provision of such care for distinct patient populations (such as healthy children, chronically ill adults, or infirm elderly individuals).

(3)

Goals

In developing such measures, the Secretary shall seek to—

(A)

address issues regarding risk adjustment, accountability, and sample size;

(B)

include the full scope of services that comprise a cycle of care; and

(C)

include multiple dimensions.

(4)

Timeframe

(A)

Acute and chronic diseases

(B)

Primary and preventive care

(July 1, 1944, ch. 373, title IX, § 931, as added and amended Pub. L. 111–148, title III, § 3013(a)(4), title X, § 10303(a), Mar. 23, 2010, 124 Stat. 381, 937.)

cite as: 42 USC 299b-31

.list_box li,p,.cm-search-info,.cm-search-detail,.abt span,.expand-collapse_top

Get the CustomsMobile app!